Participants were randomized to either daily minocycline hydrochloride (40 mg); doxycycline, the current standard of care; or ...

A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe ...